Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China · Delayed Price · Currency is CNY 12.74
+0.03 (0.24%)
Jul 30, 2026, 11:15 AM CST
SHE:002675 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 820.2 | 871.93 | 757.01 | 644.42 | 1,022 | 826.61 |
Trading Asset Securities | 172.68 | 225.22 | 148.54 | 20.12 | 27.33 | 129.27 |
Cash & Short-Term Investments | 992.88 | 1,097 | 905.55 | 664.53 | 1,049 | 955.88 |
Cash Growth | 18.46% | 21.16% | 36.27% | -36.65% | 9.74% | 14.64% |
Accounts Receivable | 1,041 | 989.89 | 936.24 | 794.08 | 883.53 | 875.48 |
Other Receivables | 21.1 | 5.05 | 0.65 | 10.96 | 62.13 | 19.06 |
Receivables | 1,062 | 994.94 | 936.89 | 805.04 | 945.66 | 894.55 |
Inventory | 494.22 | 532.57 | 646.22 | 903.86 | 1,078 | 952.53 |
Other Current Assets | 64.89 | 60.28 | 78.99 | 104.25 | 120.05 | 96.81 |
Total Current Assets | 2,614 | 2,685 | 2,568 | 2,478 | 3,193 | 2,900 |
Property, Plant & Equipment | 2,625 | 2,629 | 2,335 | 2,147 | 1,964 | 1,616 |
Long-Term Investments | 383.83 | 383.91 | 356.05 | 212.92 | 191.1 | 243.37 |
Goodwill | 2,484 | 2,491 | 2,501 | 2,544 | 2,330 | 2,373 |
Other Intangible Assets | 275.04 | 281.68 | 252.54 | 219.44 | 226.06 | 191.41 |
Long-Term Deferred Tax Assets | 144.27 | 134.66 | 94.89 | 88.03 | 63.71 | 58.61 |
Long-Term Deferred Charges | 461.79 | 444.73 | 363.02 | 243 | 133.24 | 177.03 |
Other Long-Term Assets | 191.24 | 173.43 | 164.82 | 150.37 | 76.69 | 96.54 |
Total Assets | 9,179 | 9,224 | 8,635 | 8,082 | 8,177 | 7,656 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 523.92 | 583.93 | 588.41 | 876.02 | 1,332 | 1,052 |
Accrued Expenses | 97.03 | 337.36 | 281.49 | 240.55 | 255.3 | 216.99 |
Short-Term Debt | 246.61 | 252 | 490.23 | 372.97 | 391.47 | 365.96 |
Current Portion of Long-Term Debt | 95.56 | 68.44 | 64.65 | 147.6 | 46.66 | 156.37 |
Current Portion of Leases | - | 18.14 | 9.34 | 11.39 | 4.99 | 3.69 |
Current Income Taxes Payable | 89.96 | 57.49 | 47.96 | 53.46 | 56.61 | 36.14 |
Current Unearned Revenue | 101.68 | 87.1 | 106.01 | 114.25 | 108.82 | 68.47 |
Other Current Liabilities | 376.33 | 231.55 | 165.87 | 135.48 | 197.72 | 143.11 |
Total Current Liabilities | 1,531 | 1,636 | 1,754 | 1,952 | 2,393 | 2,043 |
Long-Term Debt | 375.55 | 297.33 | 301.86 | 249.21 | 232.6 | 520.36 |
Long-Term Leases | 141.1 | 140.4 | 33.88 | 11.07 | 7.53 | 2.89 |
Long-Term Unearned Revenue | 197.43 | 192.28 | 196.79 | 236.97 | 240.27 | 47.33 |
Long-Term Deferred Tax Liabilities | 25.04 | 22.69 | 17.41 | 18.1 | 18.63 | 16.76 |
Other Long-Term Liabilities | 1,504 | 1,471 | 959.32 | 219.66 | 2.22 | 2.22 |
Total Liabilities | 3,775 | 3,760 | 3,263 | 2,687 | 2,895 | 2,633 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 824.6 | 824.6 | 824.6 | 824.6 | 824.6 | 802.21 |
Additional Paid-In Capital | 1,700 | 1,700 | 1,998 | 2,341 | 2,402 | 2,317 |
Retained Earnings | 1,847 | 1,814 | 1,643 | 1,603 | 1,517 | 1,290 |
Comprehensive Income & Other | -0.24 | 11.81 | 14.84 | 6.86 | 4.84 | -11.78 |
Total Common Equity | 4,286 | 4,350 | 4,480 | 4,775 | 4,749 | 4,397 |
Minority Interest | 1,118 | 1,114 | 891.02 | 620.22 | 533.66 | 626.35 |
Shareholders' Equity | 5,404 | 5,464 | 5,371 | 5,396 | 5,282 | 5,024 |
Total Liabilities & Equity | 9,179 | 9,224 | 8,635 | 8,082 | 8,177 | 7,656 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 858.82 | 776.32 | 899.96 | 792.23 | 683.25 | 1,049 |
Net Cash (Debt) | 134.06 | 320.83 | 5.59 | -127.7 | 365.7 | -93.39 |
Net Cash Growth | 276.05% | 5638.53% | - | - | - | - |
Net Cash Per Share | 0.16 | 0.39 | 0.01 | -0.15 | 0.45 | -0.12 |
Filing Date Shares Outstanding | 824.6 | 824.6 | 824.6 | 824.6 | 824.6 | 802.21 |
Total Common Shares Outstanding | 824.6 | 824.6 | 824.6 | 824.6 | 824.6 | 802.21 |
Working Capital | 1,083 | 1,049 | 813.69 | 525.96 | 799.34 | 856.82 |
Book Value Per Share | 5.20 | 5.28 | 5.43 | 5.79 | 5.76 | 5.48 |
Tangible Book Value | 1,527 | 1,577 | 1,727 | 2,012 | 2,193 | 1,833 |
Tangible Book Value Per Share | 1.85 | 1.91 | 2.09 | 2.44 | 2.66 | 2.28 |
Buildings | - | 1,617 | 1,490 | 1,196 | 1,119 | 869.32 |
Machinery | - | 1,291 | 1,162 | 943.15 | 870.18 | 747.8 |
Construction In Progress | - | 639.8 | 567.91 | 780.03 | 641.37 | 561.05 |